Cite
HARVARD Citation
Ward, K. et al. (2016). Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted. Respiratory medicine. pp. 131-133. [Online].